Skip to main content
logo
Galderma Group AG (SWX:GALD)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
173.65
+4.35 (2.57%)
Jul 24, 2026, 5:30 PM CET

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Neuromodulators Revenue
1.59B1.47B1.29B
Fillers & Biostimulators Revenue
1.18B1.10B1.01B
Injectable Aesthetics Revenue
2.77B2.57B2.30B
Dermatological Skincare Revenue
1.58B1.45B1.33B
Therapeutic Dermatology Revenue
1.54B1.19B780.00M
Revenue (Other)
32.00M35.00M30.00M
Revenue (Total)
5.92B5.24B4.44B

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
USA Revenue
2.57B2.23B1.81B
International Revenue
3.33B2.98B2.60B
Revenue (Other)
31.00M34.00M30.00M
Revenue (Total)
5.92B5.24B4.44B

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Neuromodulators Constant Currency Growth
14.30%11.80%
Fillers & Biostimulators Constant Currency Growth
8.00%7.00%
Injectable Aesthetics Constant Currency Growth
11.50%9.60%
Dermatological Skincare Constant Currency Growth
9.30%10.70%
Therapeutic Dermatology Constant Currency Growth
50.20%6.10%
Total Constant Currency Growth
17.70%9.30%